ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,549Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 1456

$1.48M Total Retail Price of All Prescriptions

Rank: 39 out of 1456

806 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 806 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

26% of this provider’s 806 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 16,094 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
PRAVASTATIN SODIUM 934 564 1 9
HYDROCODONE-ACETAMINOPHEN 828 499 S3 2 6
LISINOPRIL 819 522 3 3
METFORMIN HCL 687 396 4 8
TRAMADOL HCL 654 398 5 17
AMLODIPINE BESYLATE 626 438 6 1
LEVOTHYROXINE SODIUM 623 430 7 4
BENAZEPRIL HCL 503 275 8 57
TRAZODONE HCL 458 245 9 47
OMEPRAZOLE 439 296 10 5
FUROSEMIDE 416 318 11 7
RANITIDINE HCL 376 159 12 27
GEMFIBROZIL 359 175 13 117
GABAPENTIN 333 190 14 13
HYDROCHLOROTHIAZIDE 329 218 15 10
ADVAIR DISKUS 306 183 16 63
GLIMEPIRIDE 293 198 17 33
CARVEDILOL 285 169 18 20
ZOLPIDEM TARTRATE 283 209 19 14
CEFUROXIME 266 168 20 138
LOSARTAN POTASSIUM 249 174 21 16
MELOXICAM 244 164 22 30
METOPROLOL TARTRATE 242 170 23 12
NIFEDIPINE ER 232 183 24 81
MIRTAZAPINE 229 198 25 65
LYRICA 221 135 26 91
DIOVAN 217 185 27 35
CLOPIDOGREL 208 145 28 32
FLUOXETINE HCL 208 137 28 55
SERTRALINE HCL 208 115 28 25
POTASSIUM CHLORIDE 195 147 31 15
SIMVASTATIN 193 118 32 2
NEXIUM 193 139 32 23
CITALOPRAM HBR 192 95 34 22
VERAPAMIL ER 192 156 34 82
FINASTERIDE 189 145 36 110
ALLOPURINOL 188 122 37 31
CYMBALTA 186 108 38 52
PROMETHAZINE HCL 184 97 R 39 77
TAMSULOSIN HCL 182 148 40 34
PANTOPRAZOLE SODIUM 178 130 41 43
ISOSORBIDE MONONITRATE ER 176 133 42 60
BISOPROLOL-HYDROCHLOROTHIAZIDE 169 74 43 93
QUETIAPINE FUMARATE 159 69 44 78
FLUTICASONE PROPIONATE 158 116 45 28
NAMENDA 157 145 46 38
PLAVIX 157 105 46 46
DONEPEZIL HCL 155 130 48 29
HYDRALAZINE HCL 153 114 49 48
WARFARIN SODIUM 152 88 50 21
LEVETIRACETAM 147 95 51 97
LANTUS 147 78 51 50
ATORVASTATIN CALCIUM 146 98 53 11
RISPERIDONE 141 80 54 72
PROAIR HFA 135 57 55 69
KLOR-CON M10 133 105 56 140
CYCLOBENZAPRINE HCL 130 61 R 57 66
CIPROFLOXACIN HCL 125 88 58 58
AMITRIPTYLINE HCL 123 84 R 59 70
KLOR-CON M20 121 57 60 51
CRESTOR 120 57 61 26
TIZANIDINE HCL 118 71 62 116
SPIRIVA 116 79 63 75
VENLAFAXINE HCL ER 109 54 64 89
ALENDRONATE SODIUM 107 84 65 36
PAROXETINE HCL 103 54 66 67
FENOFIBRATE 101 37 67 56
LACTULOSE 99 68 68 192
ATENOLOL 98 39 69 18
BUSPIRONE HCL 94 58 70 151
INSULIN SYRINGE 93 60 71 64
AVODART 93 74 71 218
PREDNISONE 91 59 73 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 31 74 24
POLYETHYLENE GLYCOL 3350 85 32 75 85
MECLIZINE HCL 85 74 75 101
ROPINIROLE HCL 84 49 77 90
ACTOS 84 58 77 115
LOSARTAN-HYDROCHLOROTHIAZIDE 82 64 79 41
CARISOPRODOL 82 31 R 79 80
METOPROLOL SUCCINATE 81 68 81 19
JANUVIA 80 59 82 68
TRIAMTERENE-HCTZ 79 50 83 49
DIOVAN HCT 79 35 83 59
KLOR-CON 10 78 59 85 96
METOCLOPRAMIDE HCL 78 60 85 125
HYDROXYZINE PAMOATE 78 42 R 85 270
BUPROPION HCL SR 77 21 88 185
SEROQUEL 77 40 88 154
EXFORGE 68 41 90 211
DOXAZOSIN MESYLATE 68 45 90 84
DOXYCYCLINE HYCLATE 68 44 90 129
EXFORGE HCT 66 28 93 286
FLUOCINONIDE 65 46 94 314
DIVALPROEX SODIUM 64 59 95 108
PEN NEEDLE 63 46 96 131
EXELON 63 63 96 105
NOVOLOG 62 17 98 104
PRAMIPEXOLE DIHYDROCHLORIDE 61 45 99 203
BENZTROPINE MESYLATE 58 18 R 100 222
TERAZOSIN HCL 58 28 100 142
FAMOTIDINE 58 33 100 45
FLUCONAZOLE 55 21 103 148
COMBIVENT 55 43 103 110
ESCITALOPRAM OXALATE 55 41 103 74
DICLOFENAC SODIUM 54 31 106 95
VENTOLIN HFA 54 18 106 121
ZETIA 54 52 106 71
AZITHROMYCIN 53 37 109 44
ONGLYZA 53 14 109 202
TORSEMIDE 52 32 111 145
CLONIDINE HCL 51 32 112 39
ZOSTAVAX 51 40 112 187
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 30 112 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.